2 hops from the claim · 2022 · Cancer Lett
Nuclear PD-L1 promotes cell cycle progression of BRAF-mutated colorectal cancer by inhibiting THRAP3
This paper's abstract reports its own result on what it's cited for. The trail starts here.
The citing sentence
nPD‐L1 can also serve as a key nuclear protein that promotes immune‐independent cell proliferation without binding to PD‐1. [36]
What this paper says · Abstract
… Moreover, BRAF V600E-mutated CRC cells exhibited upregulation of PD-L1 expression via the transcription factor LEF-1. These findings reveal a novel role of nPD-L1, which promotes cell cycle progression in an immune-independent manner in BRAF V600E-mutated CRC. Our study provides novel insight into the mechanisms underlying BRAF V600E-mutated CRC progression.
Against the claim you started with: Changed
Readings behind this result
States what it's cited for: 92% · Own result: 96% · Read from the abstract. These are the model's probabilities; the rules that turn them into a result are under How it works.